PL2301943T3 - Krystalizacja epidaunorubicyny x HCI - Google Patents

Krystalizacja epidaunorubicyny x HCI

Info

Publication number
PL2301943T3
PL2301943T3 PL09011459T PL09011459T PL2301943T3 PL 2301943 T3 PL2301943 T3 PL 2301943T3 PL 09011459 T PL09011459 T PL 09011459T PL 09011459 T PL09011459 T PL 09011459T PL 2301943 T3 PL2301943 T3 PL 2301943T3
Authority
PL
Poland
Prior art keywords
epidaunorubicin
hci
crystallization
Prior art date
Application number
PL09011459T
Other languages
English (en)
Inventor
Tero Kunnari
Holger Bindernagel
Sascha Weiser
Andrew Lupton
Stefan Wallert
Original Assignee
Heraeus Precious Metals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41483008&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2301943(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Heraeus Precious Metals Gmbh filed Critical Heraeus Precious Metals Gmbh
Publication of PL2301943T3 publication Critical patent/PL2301943T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/252Naphthacene radicals, e.g. daunomycins, adriamycins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL09011459T 2009-09-08 2009-09-08 Krystalizacja epidaunorubicyny x HCI PL2301943T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09011459.6A EP2301943B1 (en) 2009-09-08 2009-09-08 Crystallization of epidaunorubicin x HCI

Publications (1)

Publication Number Publication Date
PL2301943T3 true PL2301943T3 (pl) 2014-06-30

Family

ID=41483008

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09011459T PL2301943T3 (pl) 2009-09-08 2009-09-08 Krystalizacja epidaunorubicyny x HCI

Country Status (16)

Country Link
US (3) US8686164B2 (pl)
EP (2) EP2636676A3 (pl)
JP (2) JP5858481B2 (pl)
KR (1) KR101480376B1 (pl)
CN (2) CN103347891B (pl)
AU (1) AU2010294532B2 (pl)
BR (1) BR112012005126A8 (pl)
CA (1) CA2772260C (pl)
HR (1) HRP20140263T1 (pl)
MX (1) MX2012002869A (pl)
PL (1) PL2301943T3 (pl)
RU (1) RU2564415C2 (pl)
SG (1) SG178461A1 (pl)
UA (1) UA111580C2 (pl)
WO (1) WO2011029576A1 (pl)
ZA (1) ZA201202405B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2636676A3 (en) 2009-09-08 2014-01-01 Heraeus Precious Metals GmbH & Co. KG Crystallization of epidaunorubicin x HCl
DE102011103751A1 (de) * 2011-05-31 2012-12-06 Heraeus Precious Metals Gmbh & Co. Kg Kristallisierung von Epirubicinhydrochlorid
KR101428340B1 (ko) * 2012-12-31 2014-08-07 현대자동차주식회사 이온성 용매를 이용한 락타이드 제조법
CA2943609A1 (en) 2014-03-27 2015-10-01 The Brigham And Women's Hospital, Inc. Metabolically-activated drug conjugates to overcome resistance in cancer therapy
DE102014208194A1 (de) * 2014-04-30 2015-11-05 Heraeus Deutschland GmbH & Co. KG Aufreinigung von Epidaunorubicin
WO2016159092A1 (ja) 2015-03-30 2016-10-06 Meiji Seikaファルマ株式会社 エピルビシンの製造方法およびその新規な製造中間体
CN109384822B (zh) * 2017-08-11 2021-08-03 鲁南制药集团股份有限公司 一种盐酸表柔比星晶型及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1506200A (en) 1975-04-30 1978-04-05 Farmaceutici Italia Glycosides
US4345068A (en) 1979-11-22 1982-08-17 Farmitalia Carlo Erba S.P.A. Process for the preparation of 4'-epidaunorubicin, 3',4'-diepidaunorubicin, their doxorubicin analogs, and intermediates used in said process
IT1155446B (it) 1982-12-23 1987-01-28 Erba Farmitalia Procedimento per la purificazione di glucosidi antraciclinonici mediante adsobimento selettivo su resine
JPS6442498A (en) * 1987-08-07 1989-02-14 Biogal Gyogyszergyar Improvement for collecting daunorubicin hydrochloride from fermentation liquid
IT1275953B1 (it) 1995-03-22 1997-10-24 Sicor Spa Procedimento per la preparazione di antibiotici della classe delle antracicline
DE69609845T2 (de) 1996-12-16 2000-12-21 Pharmachemie B.V., Haarlem Verfahren zur Herstellung von Epirubicin oder Zusatzsalzen davon, von Daunorubicin
ATE315571T1 (de) * 1997-11-28 2006-02-15 Dainippon Sumitomo Pharma Co Kristallines amrubicin-hydrochlorid
JP3900243B2 (ja) * 1997-12-05 2007-04-04 メルシャン株式会社 結晶質アントラサイクリン抗生物質およびその製造方法
NZ511093A (en) * 1998-10-16 2003-04-29 Mercian Corp Crystallization of doxorubicin hydrochloride
CN100412084C (zh) * 2003-07-02 2008-08-20 獀洛克斯股份有限公司 热稳定的结晶盐酸表柔比星及其制造方法
US8802830B2 (en) * 2005-12-20 2014-08-12 Solux Corporation Synthesis of epirubicin from 13-dihydrodaunorubicine
KR20080087148A (ko) * 2006-01-04 2008-09-30 두-쿱 테크놀로지스 리미티드 저온보호 조성물 및 그 이용방법
PL1990405T3 (pl) 2007-05-08 2018-01-31 Provivo Oy Genetycznie zmodyfikowane szczepy wytwarzające metabolity będące antracyklinami użyteczne jako leki przeciwnowotworowe
EP2262452A1 (en) * 2008-03-13 2010-12-22 Enbio Limited Surface modification of nitinol
EP2636676A3 (en) 2009-09-08 2014-01-01 Heraeus Precious Metals GmbH & Co. KG Crystallization of epidaunorubicin x HCl

Also Published As

Publication number Publication date
JP2016094445A (ja) 2016-05-26
US8822658B2 (en) 2014-09-02
BR112012005126A8 (pt) 2018-02-14
AU2010294532A1 (en) 2012-03-08
HRP20140263T1 (hr) 2014-04-25
US9434756B2 (en) 2016-09-06
ZA201202405B (en) 2012-12-27
US8686164B2 (en) 2014-04-01
US20140357848A1 (en) 2014-12-04
KR101480376B1 (ko) 2015-01-09
KR20120068023A (ko) 2012-06-26
US20140148587A1 (en) 2014-05-29
EP2636676A2 (en) 2013-09-11
CN103347891B (zh) 2016-06-01
MX2012002869A (es) 2012-09-07
SG178461A1 (en) 2012-03-29
EP2301943A1 (en) 2011-03-30
EP2301943B1 (en) 2014-01-08
CN105713055A (zh) 2016-06-29
CN103347891A (zh) 2013-10-09
AU2010294532B2 (en) 2014-04-10
RU2012113549A (ru) 2013-10-20
CA2772260C (en) 2015-02-24
UA111580C2 (uk) 2016-05-25
EP2636676A3 (en) 2014-01-01
WO2011029576A1 (en) 2011-03-17
RU2564415C2 (ru) 2015-09-27
BR112012005126A2 (pt) 2017-10-03
US20120232291A1 (en) 2012-09-13
JP2013503826A (ja) 2013-02-04
CA2772260A1 (en) 2011-03-17
JP5858481B2 (ja) 2016-02-10

Similar Documents

Publication Publication Date Title
EP2438246A4 (en) CONSTRUCTION ASPECTS
IL243287A0 (en) crystals
GB0915515D0 (en) Treatment of vasculoproliferative conditions
SG10201408584UA (en) Crystalline Methylthionium Chloride Hydrates
IL206491A0 (en) Treatment of produce
ZA201200783B (en) Crystal modification of mesotrione
PL2301943T3 (pl) Krystalizacja epidaunorubicyny x HCI
GB0905133D0 (en) Orientation of interfacing projections
GB2469543B (en) Construction of geometrical shapes
GB2468936B (en) Chlorination of sucrose-6-esters
ZA201200751B (en) Fluorinated derivatives of 3-hydroxypyridin-4-ones
SI2504309T1 (sl) Sinteza acetokslacetaldehida
EP2459540A4 (en) PREPARATION OF FIPAMEZOLE
TWM372743U (en) Improved structure of Kendama
TWM365675U (en) Improved structure of teapoy
PL2263445T3 (pl) Grupa doniczek
SI2411354T1 (sl) Stabiliziranje poliolov
GB0920588D0 (en) Splint
TWM372028U (en) Structure of wire-peeling pliers
GB2464599B (en) Attachment of can ends
TWM374127U (en) Structure of three-string Huqin
GB0905280D0 (en) Novel uses of VEGFxxxb
GB0903773D0 (en) Works of art
GB0915468D0 (en) Get me out of here
TWM372951U (en) Improvement of eyeglasses structure